SCHEMBL467098

SCHEMBL467098

CCO[SiH](OCC)OCCCCc1ccncc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 2/20 0.44
NAAA Q02083 1/20 0.38
LMNA P02545 2/20 0.38
HTT P42858 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
LOXL2 Q9Y4K0 1/20 0.37
HRH4 Q9H3N8 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP3A4 P08684 3/20 0.35
CYP2D6 P10635 3/20 0.35
CYP2C9 P11712 2/20 0.35
TSHR P16473 1/20 0.35
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C19 P33261 1/20 0.34
HIF1A Q16665 1/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4525165 0.88 LOXL2 (0.41) HRH1LMNAHTTLOXL2HRH3
SCHEMBL961404 0.85 HRH1 (0.43) HRH1NAAALMNAHTTSMN1; SMN2
SCHEMBL7765754 0.83 IDO1 (0.44) NAAATDP1L3MBTL1
SCHEMBL27652480 0.74 HRH1 (0.53) HRH1NAAALMNAHTTSMN1; SMN2
SCHEMBL18528745 0.73 HRH1 (0.44) HRH1NAAALMNAHTTSMN1; SMN2
SCHEMBL18528666 0.73 HRH1 (0.44) HRH1NAAALMNAHTTSMN1; SMN2
SCHEMBL16293859 0.73 HRH1 (0.49) HRH1NAAALMNASMN1; SMN2HRH4
SCHEMBL726645 0.73 HRH1 (0.73) HRH1NAAALMNAHTTSMN1; SMN2
SCHEMBL2093952 0.73 HRH1 (0.57) HRH1NAAALMNAHTTSMN1; SMN2
SCHEMBL369568 0.72 HRH1 (0.59) HRH1NAAALMNAHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 612 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250154325-A1 VANILLIC ACID-BASED ORGANIC-INORGANIC COMPOUND, CURABLE COMPOSITION, AND PRODUCTION METHOD THEREOF ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE (KR) 2025-05-15 US claimed
US-12290798-B2 Method for obtaining metal oxides supported on mesoporous silica particles Technische Universität Berlin (DE) 2025-05-06 US claimed
US-20250019568-A1 Tungsten Chemical Mechanical Polishing Slurries VERSUM MATERIALS US, LLC 2025-01-16 US claimed
US-20240096563-A1 Wet Electrolytic Capacitor Containing A Gelled Working Electrolyte KYOCERA AVX Components Corporation 2024-03-21 US claimed
WO-2024044019-A1 WET ELECTROLYTIC CAPACITOR CONTAINING A GELLED WORKING ELECTROLYTE KYOCERA AVX Components Corporation (US) 2024-02-29 WO claimed
CN-117186407-A Organic-inorganic composite, method for preparing the same, and curable composition comprising the same 韩国电子通信研究院 2023-12-08 CN claimed
US-20230391956-A1 SILYL ETHER ISOHEXIDE-BASED ORGANIC-INORGANIC COMPOUND, METHOD FOR PREPARING THE SAME, AND CURABLE COMPOSITION CONTAINING THE SAME ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE (KR) 2023-12-07 US claimed
US-11823846-B2 Solid electrolytic capacitor containing a pre-coat and intrinsically conductive polymer KYOCERA AVX Components Corporation (US) 2023-11-21 US claimed
US-11781066-B2 Wet etching composition and method ENTEGRIS, INC. (US) 2023-10-10 US claimed
US-11776760-B2 Solid electrolytic capacitor containing polyaniline KYOCERA AVX Components Corporation (US) 2023-10-03 US claimed
WO-2012166916-A1 METHOD OF SEPARATION OF LIPID AND BIOLOGICAL MOLECULAR SPECIES USING HIGH PURITY CHROMATOGRAPHIC MATERIALS WATERS TECHNOLOGIES CORPORATION (US) 2012-12-06 WO claimed
US-20120273404-A1 HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER WATERS TECHNOLOGIES CORPORATION (US) 2012-11-01 US claimed
EP-2483442-A1 SOLUTION AND METHOD FOR ACTIVATING THE OXIDIZED SURFACE OF A SEMICONDUCTOR SUBSTRATE Alchimer (FR) 2012-08-08 EP claimed
US-20120196441-A1 SOLUTION AND METHOD FOR ACTIVATING THE OXIDIZED SURFACE OF A SEMICONDUCTOR SUBSTRATE ALCHIMER (FR) 2012-08-02 US claimed
WO-2012092142-A1 CURABLE SILICATE-SILOXANE MIXED MATRIX MEMBRANE COMPOSITIONS DOW CORNING CORPORATION (US) 2012-07-05 WO claimed
EP-2462188-A1 HIGH PURITY CHROMATROGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER Waters Technologies Corporation (US) 2012-06-13 EP claimed
WO-2012051487-A1 SILICON-CONTAINING MATERIALS WITH CONTROLLABLE MICROSTRUCTURE DOW CORNING CORPORATION (US) 2012-04-19 WO claimed
US-20120081778-A1 PIGMENT-BASED INK HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2012-04-05 US claimed
WO-2011039310-A1 SOLUTION AND METHOD FOR ACTIVATING THE OXIDIZED SURFACE OF A SEMICONDUCTOR SUBSTRATE ALCHIMER (FR) 2011-04-07 WO claimed
WO-2011017418-A1 HIGH PURITY CHROMATROGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER WATERS TECHNOLOGIES CORPORATION (US) 2011-02-10 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120273404-A1 HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER SPECC1L, SAMM50, RAB5IF HRH1 1811/4885NAAA 488/4885LMNA 614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.